Dave Muoio

July 17, 2019
Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning. Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales...
July 17, 2019
Withings announced this morning that it is updating its connected blood pressure cuff product line with two new offerings: a revamped version of its existing at-home cuff, and a premium cardiac monitor with onboard ECG functionality. The former device is the Withings BPM Connect ($99.95/€99.95/£89.95), an FDA-cleared and CE-compliant consumer product for monitoring systolic pressure, diastolic...
July 16, 2019
The first half of 2019 has been bigger for digital health than any year opening before it, according to a new funding report from Mercom Capital Group. While these conclusions were similar to those of MobiHealthNews and Rock Health, both released earlier this month, Mercom’s count pegged 2019’s to-date funding a bit higher at $5.1 billion raised through 318 deals (2018 saw $4.9 billion from 383...
July 16, 2019
Wave, a subscription app and connected foam cushion for at-home meditation, has launched with $5.65 million in seed funding. CrossLink Capital, Lerer Hippeau Ventures, Collaborative Fund and Ludlow Ventures were named as the company’s backers in this morning’s announcement. WHAT THEY DO The core of Wave’s consumer offering is an app-based service ($9.99 per month, $99.99 for a year) that looks to...
July 15, 2019
Patients who enrolled in a physical activity trial enjoyed a long-term benefit of fewer cardiovascular events and bone fractures up to four years after the intervention was completed. According to a new review of these patients’ routine primary care records published in PLoS Medicine, the data support further rollout of pedometer-based walking programs among older adults, even if the intervention...
July 15, 2019
This morning Mahmee, a Los Angeles-based platform offering pre- and postpartum support to mothers and providers, announced $3 million in new funding headed by ArlanWasHere Investments. Other participants included Mark Cuban, Serena Williams’ Serena Ventures and Revolution’s Rise of the Rest Seed Fund. WHAT THEY DO Mahmee’s tool works within a provider’s IT system to link a mother and child’s...
July 15, 2019
Echelon Fitness Multimedia, maker of Echelon Fit connected spin bikes and on-demand digital workouts, has received an infusion of growth capital from North Castle Partners. The companies declined to specify the size of this investment, but told MobiHealthNews that it brings Echelon’s business to a total value of $100 million. WHAT THEY DO On the surface, Echelon Fit — a standalone entity launched...
July 11, 2019
Telehealth and mail-order health and wellness consumer brands Hims & Hers have been joined by Dr. Pat Carroll. Formerly a chief medical officer at Walgreens and a 20,000-patient primary care group, Carroll take on a similar role for the growing startup. “Our vision is an ecosystem where people have plenty of options to get the care that’s right for them. Depending on what they need, that...
July 11, 2019
The FCC’s Connected Care Pilot Program — a three-year, $100 million telehealth initiative that was first proposed last summer — took another step toward fruition yesterday with the commission’s unanimous vote to advance and seek public comment on the project. Alongside general questions on the program’s budgeting, duration and structure, the new Notice of Proposed Rulemaking is searching for...
July 10, 2019
Clover Health, an Alphabet-backed insurtech startup serving the Medicare Advantage market, announced this morning the launch of a new subsidiary unit that will be focused on using data from its members to drive drug development. Much like its parent company uses machine learning and artificial intelligence to generate predictive health insights for its member population, Clover Therapeutics will...